Concepedia

Antje Danielczyk

AD

10

Publications

419

Citations

10

H-Index

2002

Active since

Affiliations

Glycotope (Germany)(Current)

Universität Hamburg

University Cancer Center Hamburg

Max Delbrück Center

University Medical Center Hamburg-Eppendorf

Antje Danielczyk is an author at Glycotope (Germany) specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2002–2018

10

Publications

10

PankoMab: a potent new generation anti-tumour MUC1 antibody

Antje Danielczyk, Renate Stahn, Dorian Faulstich et al. · Cancer Immunology Immunotherapy · 2006 · 125 citations · Full text

, , +2

Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K521 Polymorphism

Friederike Braig, Malte Kriegs, Minna Voigtlaender et al. · Cancer Research · 2016 · 77 citations

Functional Activation of the Formyl Peptide Receptor by a New Endogenous Ligand in Human Lung A549 Cells

Ursula Rescher, Antje Danielczyk, Arseni Markoff et al. · The Journal of Immunology · 2002 · 74 citations · Full text

Multivalent scFv Display of Phagemid Repertoires for the Selection of Carbohydrate-specific Antibodies and its Application to the Thomsen–Friedenreich Antigen

Peter Ravn, Antje Danielczyk, Kim B. Jensen et al. · Journal of Molecular Biology · 2004 · 43 citations

, , +12

Glyco-Engineered Anti-Human Programmed Death-Ligand 1 Antibody Mediates Stronger CD8 T Cell Activation Than Its Normal Glycosylated and Non-Glycosylated Counterparts

Christoph Goletz, Timo Lischke, Ulf Harnack et al. · Frontiers in Immunology · 2018 · 28 citations · Full text

Rows per page

1–5 of 10